ea0044ep95 | (1) | SFEBES2016
Nagi Dinesh
, Holems Simon
, Jenkins Richard
We describe an interesting case of a man who poses a significant ongoing management challenge. He presented with mild biochemical evidence of T3 thyrotoxicosis (FT3, 8.2, FT4 13.6, TSH 0.02). Carbimazole 20 mg was started and despite increasing dosage, he deteriorated significantly. He was concordant with medication. His TBII and thyroid auto-antibodies were negative. A Tc uptake scan showed reduced uptake. Prednisolone was added, thinking that he may have thyroiditis. Despite...